Allergy Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	665	379	250	7	134	160
Market Cap Growth	116.28%	51.72%	3402.67%	-94.66%	-16.71%	80.14%
Enterprise Value	682	402	246	2	102	124
Last Close Price	0.10	0.08	0.05	0.00	0.10	0.12
PE Ratio	-	-	-	-	-	55.59
PS Ratio	11.61	6.88	4.53	0.12	1.84	1.90
PB Ratio	156.49	-13.44	33.95	3.45	3.54	3.31
P/TBV Ratio	13569.71	-	93.58	-	4.08	3.67
P/FCF Ratio	-	-	-	-	-	26.62
P/OCF Ratio	-	-	-	-	-	18.68
PEG Ratio	-	5.65	5.65	5.65	5.65	5.65
EV/Sales Ratio	11.90	7.30	4.46	0.03	1.40	1.47
EV/EBITDA Ratio	-	-	-	-	-	20.31
EV/EBIT Ratio	-	-	-	-	-	31.62
EV/FCF Ratio	-18.34	-	-	-	-	20.60
Debt / Equity Ratio	6.30	-2.13	4.21	17.42	0.28	0.23
Debt / EBITDA Ratio	-	-	-	-	-	1.44
Debt / FCF Ratio	-	-	-	-	-	1.85
Net Debt / Equity Ratio	3.92	-1.68	2.46	10.23	-0.26	-0.60
Net Debt / EBITDA Ratio	-0.53	-1.81	-0.56	-0.64	0.98	-4.76
Net Debt / FCF Ratio	-0.45	-1.51	-0.51	-0.63	0.59	-4.83
Asset Turnover	0.80	0.82	0.83	0.85	0.90	0.97
Inventory Turnover	2.13	1.93	2.09	2.29	2.09	2.11
Quick Ratio	0.70	0.69	1.02	1.07	1.46	2.46
Current Ratio	1.13	1.27	1.78	1.81	2.35	3.17
Return on Equity (ROE)	-	-	-819.81%	-216.27%	-31.93%	6.25%
Return on Assets (ROA)	-29.64%	-26.58%	-32.23%	-31.48%	-9.60%	2.81%
Return on Invested Capital (ROIC)	-163.21%	-127.92%	-141.18%	-138.02%	-52.41%	16.12%
Return on Capital Employed (ROCE)	-87.60%	-70.60%	-72.10%	-73.00%	-22.50%	5.60%
Earnings Yield	-7.25%	-10.59%	-15.46%	-604.03%	-10.31%	1.80%
FCF Yield	-5.59%	-8.28%	-14.23%	-470.51%	-12.76%	3.76%
Buyback Yield / Dilution	-4.81%	-27.33%	-458.41%	-4.26%	4.98%	-0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.